Congress President Office

Diagnostic Radiology and
Radiation Oncology,
Graduate School of Medicine,
Chiba University
1-8-1 Inohana, Chuo-ku,
Chiba City, Chiba,
260-8670, Japan

Congress Secretariat

c/o Congrès Inc.
Onward Park Bldg.,
3-10-5 Nihonbashi,
Chuo-ku, Tokyo,
103-8276, JAPAN
TEL: +81-3-3510-3701
E-mail:
jastro2026@m.congre.co.jp

Program/Time table

Friday, November 13

Presidential Lecture ASTRO & ESTRO 8:30~9:30 Room5

Chairs Takashi Uno Department of Diagnostic Radiology and Radiation Oncology,
Graduate School of Medicine, Chiba University
Masahiko Aoki Hirosaki University
Speakers PL-1 Current status and future direction of radiation oncology in ASTRO
Vivek S. Kavadi American Society for Radiation Oncology
PL-2 INCREASING TREATMENT EFFICIENCY WITH ON-LINE ADAPTIVE RADIOTHERAPY
Uulke van der Heide The Netherlands Cancer Institute, Amsterdam and ESTRO

ASTRO-ESTRO-JASTRO Symposium 9:40~10:55 Room5

Adaptive Radiation Therapy

Chairs Hidefumi Aoyama Department of Radiation Oncology, Hokkaido University
Mariko Kawamura Dept. of Radiology/Radiation Oncology, Nagoya University,
Graduate School of Medicine
Sameer Keole Mayo Clinic, Phoenix
Speakers AEJ-1 Ablative Radiotherapy for Locally Advanced Pancreatic Cancer:
The Emerging Role of MR Guided Adaptive Radiotherapy
Christopher Crane Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center
AEJ-2 THE ART OF PRECISION IN RADIOTHERAPY
Uulke van der Heide The Netherlands Cancer Institute, Amsterdam and ESTRO
AEJ-3 The current status of CBCT-guided oART in Japan and our initial experience with oART
Michio Yoshimura Department of Radiation Oncology & Image-applied Therapy, Kyoto University
AEJ-4 MR-guided Online Adaptive Radiotherapy with Comprehensive Motion Management for Liver Tumors
Makoto Saito Chiba University Hospital

Conference Theme Session 4 15:10~17:10 Room3

Stereotactic Radiation Therapy

Chairs Takashi Mizowaki Radiation Oncology & Image-Applied Therapy, Graduate
School of Medicine, Kyoto University
Hiroshi Igaki Department of Radiation Oncology, National Cancer Center Hospital
Speakers AT4-1 【Keynote Speech】SBRT for primary renal cell carcinoma;
from the FASTRACK trials to the clinic
Shankar Siva Peter MacCallum Cancer Centre/University of Melbourne
AT4-2 The “Acceptable” is No Longer acceptable.
Comparing Efficacy and Safety Across Targeted CNS Radiation Regimens
Timothy Chen Hackensack Meridian Health, USA
AT4-3 The Past, Present, and Future of Stereotactic Body Radiation Therapy for Lung Cancer
Tomoki Kimura Department of Radiation Oncology, Kochi Medical School Hospital
AT4-4 The role of SBRT for Liver Tumors: Current Evidence and Future Perspectives
Atsuya Takeda Department of Radiology, Keio University School of Medicine

PAGE TOP